or Try an Advanced Search...

    Immune Checkpoint Stocks List

    Symbol Grade Name % Change
    CRVS A Corvus Pharmaceuticals, Inc. 2.94
    CKPT A Checkpoint Therapeutics, Inc. 2.03
    XLO B Xilio Therapeutics, Inc. 3.94
    CMPX B Compass Therapeutics, Inc. 3.66
    BOLT C Bolt Biotherapeutics, Inc. 3.75
    BCYC D Bicycle Therapeutics plc -3.13
    LIXT D Lixte Biotechnology Holdings, Inc. -4.27
    EQ D Equillium, Inc. -3.60
    BCTX F BriaCell Therapeutics Corp. -2.30
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Medicine Immune System Biotechnology Cancer Immunotherapy Clinical Medicine Immunology Tumor Cancer Oncology Antibodies Biopharmaceutical Breast Cancer Checkpoint Inhibitor Clinical Development Immunotherapy Life Sciences Monoclonal Antibody National Cancer Institute Tumor Microenvironment Adenosine

    Related ETFs - A few ETFs which own one or more of the above listed Immune Checkpoint stocks.

    Symbol Grade Name Weight
    MEDI D Harbor Health Care ETF 2.83
    MEDX D Horizon Kinetics Medical ETF 1.96
    CNCR F Loncar Cancer Immunotherapy ETF 1.37
    CANC C Tema Oncology ETF 0.93
    BBC B Virtus LifeSci Biotech Clinical Trials ETF 0.8
    View all Immune Checkpoint ETFs...
    Compare ETFs
    Compare CANC to BBC Compare CNCR to BBC Compare MEDX to CANC

        Immune Checkpoint Stocks Recent News

        Date Stock Title
        Oct 31 EQ Equillium says Ono not acquiring itolizumab, stock craters 36%
        Oct 31 EQ Travere Therapeutics (TVTX) Reports Q3 Loss, Tops Revenue Estimates
        Oct 31 BCYC Bicycle Therapeutics GAAP EPS of -$0.74 beats by $0.02, revenue of $2.68M misses by $4.33M
        Oct 31 EQ Equillium Maintains Rights to Itolizumab Following Ono Partnership
        Oct 31 BCYC Bicycle Therapeutics Reports Recent Business Progress and Third Quarter 2024 Financial Results
        Oct 31 EQ Why Carvana Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket
        Oct 30 XLO Xilio Therapeutics to Present Initial Phase 1C Dose Escalation Data for XTX101 (Vilastobart) in Combination with Atezolizumab in a Late-Breaker Poster at the Society for Immunotherapy of Cancer (SITC) 39th Annual Meeting
        Oct 29 LIXT Why VF Corp Shares Are Trading Higher By Around 21%; Here Are 20 Stocks Moving Premarket
        Related Industries: Biotechnology
        Related Stock Lists: Medicine Immune System Biotechnology Cancer Immunotherapy Clinical Medicine Immunology Tumor Cancer Oncology Antibodies Biopharmaceutical Breast Cancer Checkpoint Inhibitor Clinical Development Immunotherapy Life Sciences Monoclonal Antibody National Cancer Institute Tumor Microenvironment Adenosine
        Immune Checkpoint

        Immune checkpoint inhibitors are a type of cancer treatment that works by blocking certain proteins made by some types of immune system cells. These proteins, known as checkpoints, help keep the immune system from attacking normal cells in the body. By blocking these checkpoints, the immune system is able to recognize and attack cancer cells. Immune checkpoint inhibitors are used to treat a variety of cancers, including melanoma, lung cancer, bladder cancer, and kidney cancer.

        Browse All Tags